APTEVO THERAPEUTICS INC (APVO)
US03835L3069 - Common Stock
Aptevo Therapeutics Reports 3Q 2024 Financial Results and Provides a Business Update
These stocks are moving in today's after hours session
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
These stocks are moving in today's after hours session
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q2 2024
APVO stock results show that Aptevo Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth diving into this morning and we have all of the hottest news worth checking out on Thursday!
Aptevo Therapeutics Announces Closing of $2.75 Million Offering
Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We have all of the biggest pre-market stock movers that investors are going to want to keep an eye on for Monday morning!
Aptevo Participating in the BIO International Convention
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q1 2024
APVO stock results show that Aptevo Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aptevo Therapeutics (NASDAQ:APVO) just reported results for the first quarter o...
Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday!